Clinical Trials/jRCT2080221434

jRCT2080221434UnknownPhase 2

M518101 phase 2b study in plaque psoriasis patients - comparison study 2 -

Maruho Co.,Ltd.0 sitesStarted: TBD

Conditions

Trial Snapshot

Phase: Phase 2
Sponsor: Maruho Co.,Ltd.
Primary Endpoint: -

Study Overview Study Design Eligibility Criteria Outcomes Investigators Records & Identifiers Similar Trials

Study Overview

Brief Summary

No summary available.

Study Design

Study Type: Interventional
Intervention Model: Randomised, Open-labeled, Multi Centre

Eligibility Criteria

Ages: 16age old over to No limit (—)
Sex: All

Inclusion Criteria

•Patients diagnosed with plaque psoriasis

Exclusion Criteria

Not provided

Outcomes

Primary Outcomes

-

serum calcium level

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor

Maruho Co.,Ltd.

Similar Trials

M518101 phase 2b study in plaque psoriasis patients - comparison study 2Plaque psoriasis

JPRN-jRCT2080221434Maruho Co.,Ltd.

M518101 phase 2b study in plaque psoriasis patients - comparison study 1Plaque psoriasis

JPRN-jRCT2080221433Maruho Co.,Ltd.

M518101 phase 2b study in plaque psoriasis patients - comparison study 3 -Plaque psoriasis

jRCT2080222091Maruho Co.,Ltd.

M518101 phase 2b study in plaque psoriasis patients - comparison study 3Plaque psoriasis

JPRN-jRCT2080222091Maruho Co.,Ltd.

M518101 phase III study in plaque psoriasis patientsPlaque psoriasis

jRCT2080222894Maruho Co.,Ltd.